CRYSVITA sol inj 30 mg/1ml flac
7680668010035
CH-66801
M05BX05
07.99.0.
1 / 2
google
Details
- Product number
- 6680103
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- burosumabum 30 mg, histidinum, sorbitolum 45.91 mg, polysorbatum 80, methioninum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Crysvita 30 mg/1 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
45.91 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Kyowa Kirin Sàrl
1201 Genève
Authorization information
- Swissmedic authorization number
- 66801
- Drug name
- Crysvita, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- M05BX05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 20/01/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CRYSVITA sol inj 30 mg/1ml flac
- Description (DE)
- CRYSVITA Inj Lös 30 mg/1ml Durchstf
- Market launch
- 20/01/2020
- Narcotic (BTM)
- No